Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mila S Etropolski

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pain Physician|February 2, 2010
Dose conversion between tapentadol immediate and extended release for low back painMila S Etropolski, Akiko Okamoto, Douglas Y Shapiro, et al.
Diabetes Care|May 23, 2014
A randomized withdrawal, placebo-controlled study evaluating the efficacy and tolerability of tapentadol extended release in patients with chronic painful diabetic peripheral neuropathyAaron I Vinik, Douglas Y Shapiro, Christine Rauschkolb, et al.
Journal of Opioid Management|December 20, 2013
Pharmacokinetic evaluation of tapentadol extended-release tablets in healthy subjectsPeter N Zannikos, Johan W Smit, Hans-Jürgen Stahlberg, et al.
Pain Physician|July 24, 2014
Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related painHans G Kress, E Dietlind Koch, Hristiyan Kosturski, et al.
Clinical Drug Investigation|December 16, 2014
A pooled analysis evaluating the efficacy and tolerability of tapentadol extended release for chronic, painful diabetic peripheral neuropathySherwyn Schwartz, Mila S Etropolski, Douglas Y Shapiro, et al.
Clinical Drug Investigation|July 1, 2010
Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III studyMarc Afilalo, Mila S Etropolski, Brigitte Kuperwasser, et al.
Pain Practice : the Official Journal of World Institute of Pain|July 7, 2010
Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis painJames E Wild, Stefan Grond, Brigitte Kuperwasser, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pain Physician|February 2, 2010
Dose conversion between tapentadol immediate and extended release for low back painMila S Etropolski, Akiko Okamoto, Douglas Y Shapiro, et al.
Diabetes Care|May 23, 2014
A randomized withdrawal, placebo-controlled study evaluating the efficacy and tolerability of tapentadol extended release in patients with chronic painful diabetic peripheral neuropathyAaron I Vinik, Douglas Y Shapiro, Christine Rauschkolb, et al.
Journal of Opioid Management|December 20, 2013
Pharmacokinetic evaluation of tapentadol extended-release tablets in healthy subjectsPeter N Zannikos, Johan W Smit, Hans-Jürgen Stahlberg, et al.
Pain Physician|July 24, 2014
Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related painHans G Kress, E Dietlind Koch, Hristiyan Kosturski, et al.
Clinical Drug Investigation|December 16, 2014
A pooled analysis evaluating the efficacy and tolerability of tapentadol extended release for chronic, painful diabetic peripheral neuropathySherwyn Schwartz, Mila S Etropolski, Douglas Y Shapiro, et al.
Clinical Drug Investigation|July 1, 2010
Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III studyMarc Afilalo, Mila S Etropolski, Brigitte Kuperwasser, et al.
Pain Practice : the Official Journal of World Institute of Pain|July 7, 2010
Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis painJames E Wild, Stefan Grond, Brigitte Kuperwasser, et al.
Pageof 1